| Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer's disease |
23 |
| Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202 |
12 |
| Current applications of antibody microarrays |
12 |
| A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma |
9 |
| Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinization |
9 |
| Comparison of iTRAQ and SWATH in a clinical study with multiple time points |
9 |
| Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis |
8 |
| Quantitative proteomic analyses of CD4(+) and CD8(+) T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls |
8 |
| Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel |
8 |
| Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB) |
7 |
| Age-associated changes in human tear proteome |
7 |
| Investigation of post-translational modifications in type 2 diabetes |
7 |
| Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer |
7 |
| Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns |
7 |
| Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA |
6 |
| The plasma peptides of ovarian cancer |
6 |
| Discovery of non-invasive biomarkers for the diagnosis of endometriosis |
6 |
| Residual tissue repositories as a resource for population-based cancer proteomic studies |
6 |
| The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature |
6 |
| Proteomic profiling of liver tissue from the mdx-4cv mouse model of Duchenne muscular dystrophy |
6 |
| N-GlycositeAtlas: a database resource for mass spectrometry-based human N-linked glycoprotein and glycosylation site mapping |
6 |
| Validation of a novel model for the early detection of hepatocellular carcinoma |
5 |
| Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma |
5 |
| A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer |
5 |
| Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer |
5 |
| A robust mass spectrometry method for rapid profiling of erythrocyte ghost membrane proteomes |
4 |
| High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation |
4 |
| Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms |
4 |
| Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage |
4 |
| Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis |
4 |
| Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts |
4 |
| Proteomics analysis of colon cancer progression |
4 |
| Quantitative analysis of Mycobacterium avium subsp. hominissuis proteome in response to antibiotics and during exposure to different environmental conditions |
4 |
| Antigen 85B peptidomic analysis allows species-specific mycobacterial identification |
4 |
| Quality assessment and interference detection in targeted mass spectrometry data using machine learning |
4 |
| Phosphotyrosine profiling of human cerebrospinal fluid |
3 |
| Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers: results from a population-based proteomics study |
3 |
| Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure |
3 |
| Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread |
3 |
| Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis |
3 |
| Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure |
3 |
| The plasma peptidome |
3 |
| Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer |
3 |
| Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy |
3 |
| Proteomic analysis of serum proteins from HIV/AIDS patients with Talaromyces marneffei infection by TMT labeling-based quantitative proteomics |
3 |
| Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules |
3 |
| Screening differentially expressed proteins from co-cultured hematopoietic cells and bone marrow-derived stromal cells by quantitative proteomics (SILAC) method |
3 |
| Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry |
3 |
| Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases |
2 |
| iTRAQ-based analysis of sperm proteome from normozoospermic men achieving the rescue-ICSI pregnancy after the IVF failure |
2 |
